Celsus Timolol Maleate

Celsus Timolol Maleate

timolol

Manufacturer:

Ashford Pharma

Distributor:

Celsus
Concise Prescribing Info
Contents
Timolol maleate
Indications/Uses
Reduction of elevated IOP in patients w/ ocular HTN, chronic open-angle glaucoma, aphakia & glaucoma, secondary glaucoma, narrow-angle & a history of spontaneous or latronigically-induced narrow-angle closure in the opposite eye in whom reduction of IOP is necessary.
Dosage/Direction for Use
1 drop in the affected eye(s) bid. Max: 1 drop bid.
Contraindications
Hypersensitivity. Bronchial asthma or severe COPD. Sinus bradycardia; 2nd or 3rd degree AV block; overt cardiac failure; cardiogenic shock.
Special Precautions
Patient w/ history of severe cardiac problem; already receiving β-adrenergic blocking agent. Control cardiac disease adequately before therapy. Resp complications in patient w/ asthma & cardiac complications. Concomitant use of 2 topical β-adrenergic blocking agents.
Adverse Reactions
Burning & stinging, discharge, foreign body sensation, itching of the eye; ocular irritation including conjunctivitis, blepharitis, keratitis, decreased corneal sensitivity & dry eyes; bradycardia, arrhythmia, hypotension, syncope, heart block, CV accident, cerebral ischemia, CHF, palpitation, cardiac arrest, edema, claudication, Raynaud's phenomenon, cold hands & feet; bronchospasm, resp failure, dyspnea, cough; headache, asthenia, fatigue, chest pain; alopecia, psoriasiform rash or exacerbation of psoriasis; allergic reactions including angioedema, urticaria, localized & generalized rash; dizziness, depression, insomnia, nightmares, memory loss, paresthesia; increased signs & symptoms of myasthenia gravis; nausea, diarrhea, dyspepsia, dry mouth; decreased libido, Peyronie's disease; SLE.
MIMS Class
Antiglaucoma Preparations
ATC Classification
S01ED01 - timolol ; Belongs to the class of beta blocking agents. Used in the treatment of glaucoma.
Presentation/Packing
Form
Celsus Timolol Maleate eye drops 0.5 %
Packing/Price
5 mL x 1's (P320/container)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in